Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe2+ accumulation
- 4 February 2023
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 112, 154701
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Ovarian Cancer: An Integrated ReviewSeminars in Oncology Nursing, 2019
- A Dual Role of Heme Oxygenase-1 in Cancer CellsInternational Journal of Molecular Sciences, 2018
- Heme oxygenase-1 mediates BAY 11–7085 induced ferroptosisCancer Letters, 2018
- Platelet-Derived Growth Factor D Is a Prognostic Biomarker and Is Associated with Platinum Resistance in Epithelial Ovarian CancerInternational Journal of Gynecological Cancer, 2018
- Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancerCancer Letters, 2016
- Ferroptosis: Death by Lipid PeroxidationTrends in Cell Biology, 2016
- Heme oxygenase-1 accelerates erastin-induced ferroptotic cell deathOncotarget, 2015
- A novel targeted proteomics method for identification and relative quantitation of difference in nitration degree of OGDH between healthy and diabetic mouseProteomics, 2014
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012